Polyprodrug Antimicrobials:Remarkable MembraneDamage and Concurrent Drug Release to Combat Antibioti

来源 :第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con | 被引量 : 0次 | 上传用户:ylg_lanxi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  The increased threat of antibiotic resistance is urgent for new strategy.Herein,polyprodrug antimicrobials are proposed to mimic antimicrobial peptides appended with concurrent drug release property,exhibiting broad-spectrum antibacterial activity and especially high potency to inhibit methicillin-resistant Staphylococcus aureus(MRSA)without inducing resistance.
其他文献
Herein,poly(L-lactic acid)(PLLA)nanofibrous spongy microspheres(NFSMS),PLLA/polyethylene glycol(PEG)co-functionalized mesoporous silica nanoparticles(MSN),and poly(lactic acid-co-glycolic acid)microsp
会议
Generation of tumor-specific T cells is critically important for cancer immunotherapy.A major challenge in achieving a robust adaptive T cell response is the spatio-temporal orchestration of antigen c
会议
Our previous work demonstrated that Wnt16 expression in cisplatin-damaged tumor-associated fibroblasts is a key factor contributing to cisplatin resistance in malignancies.Natural antifibrotic compoun
会议
With the recent advances of cancer immunotherapy,cancer vaccines have regained the attention of academia and the pharmaceutical industry for their potential synergy with existing therapies [1,2].
会议
More and more researches have revealed that chemotherapy drugs not only induce tumor cell apoptosis but also activate autophagy.Ambroxol(Ax)as a molecular chaperone could activate coordinated lysosoma
会议
The outcome of molecular targeted therapies is restricted by the ambiguous molecular subtypes of non-small cell lung cancer(NSCLC)which are difficult to be defined with druggable mutations,and the ine
会议
Cancer immunotherapies by training or stimulating the inherent immunological systems to recognize,attack,and eradicate tumour cells with minimal damage to healthy cells have demonstrated promising cli
会议
We developed an anticancer siRNA delivery system(named HLPR)having the functions of CD44 and epidermal growth factor receptor(EGFR)dual-targeting through modular strategy without the chemical covalenc
会议
Targeting ligands are anticipated to facilitate precise delivery of therapeutic agents to diseased tissues by recognizing the overexpressed corresponding receptors; however,they may also severely affe
会议
Photo-induced cancer therapy features high selectivity,low systemic toxicity,negligible drug resistance,and noninvasive modality.To date,several types of photosensitizers including phthalocyanine,and
会议